First published on the Steem blockchain by @remlaps on May 04, 2024. View the original post.
Modern immunotherapy is making strides to improve the odds for brain cancer patients.
Many people may remember that Senator Edward (Ted) Kennedy was diagnosed with brain cancer in May, 2008, and died from it about 15 months later, in August of 2009. For me, Kennedy's cancer progression was one of those news cycles that intersected with the personal life, because my mother was diagnosed with brain cancer around the same time, in the summer of 2009, and she died from it half a year later, in January of 2010.
One of my lasting memories about Kennedy's death is the pessimistic tone of commentary from media personalities at the time. As they commented on the almost hopeless odds that Kennedy was facing, I was - of course - thinking about how their commentary applied to my own mother. And it turned out that they were right. My mom tried surgical treatment and chemotherapy, but in the end it didn't seem to make much difference. In a mere few months, she went from a healthy and vibrant retiree traveling around the country to a wheelchair bound cancer patient, and even that stage passed quickly. In a few more months, she was gone at the relatively young age of 61.
Image by Bing Creator |
As a result of this experience, it always catches my attention when I come across news about advances in the treatment of brain cancer. This week, my RSS feed contained some news of this nature. The articles, New Vaccine For Deadly Brain Cancer Shows Incredible Results in Clinical Trial and Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from within describe some promising results from a clinical trial of a new vaccine for brain cancer. Both of those articles are commentaries on newly published research from Cell, RNA aggregates harness the danger response for potent cancer immunotherapy.
As with the treatment covered in my recent article, Revolutionary Canine Cancer Vaccine Shows Promising Results: A Ray of Hope for Man's Best Friend, the product is called a vaccine, but it is only used after a cancer diagnosis. This is explained in Nature's YouTube video, below:





























